The Oncology Institute to Participate at Upcoming Investor Conferences
The Oncology Institute to Participate at Upcoming Investor Conferences
CERRITOS, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI's Chief Executive Officer, will participate at the following investor conferences:
加利福尼亞州塞裏託斯，2024 年 5 月 29 日（GLOBE NEWSWIRE）— 腫瘤學研究所有限公司 納斯達克股票代碼：TOI）是該國最大的基於價值的腫瘤學診所之一，今天宣佈，TOI首席執行官丹尼爾·維爾尼奇博士將參加以下投資者會議：
Jefferies Global Healthcare Conference
Date: June 6th, 2024
Fireside Chat: 9:00am Eastern Time
TOI Participant: Daniel Virnich, M.D., MBA, Chief Executive Officer
Location: New York City, NY
傑富瑞全球醫療保健會議
日期：6月6日第四，2024
爐邊聊天：美國東部時間上午 9:00
TOI 參與者：丹尼爾·維爾尼奇，醫學博士，工商管理碩士，首席執行官
地點：紐約州紐約市
Truist Securities Healthcare Disruptors & Digital Health Summit
Date: June 26th, 2024
Panel: 1:00pm Eastern Time
TOI Participant: Daniel Virnich, M.D., MBA, Chief Executive Officer
Location: New York City, NY
Truist Securities 醫療保健顛覆者與數字健康峯會
日期：6月26日第四，2024
小組討論：美國東部時間下午 1:00
TOI 參與者：丹尼爾·維爾尼奇，醫學博士，工商管理碩士，首席執行官
地點：紐約州紐約市
Interested investors and other parties may listen to simultaneous webcasts of the presentations by logging onto the Investor Relations section of the Company's website at https://investors.theoncologyinstitute.com/. The online replay will be available for a limited time shortly following the call.
感興趣的投資者和其他各方可以通過登錄公司網站的 “投資者關係” 欄目收聽同步的演講網絡直播，網址爲 https://investors.theoncologyinstitute.com/。電話會議結束後不久，在線重播將在限定時間內提供。
About The Oncology Institute, Inc.
關於腫瘤研究所有限公司
Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
腫瘤學研究所及其附屬公司（納斯達克股票代碼：TOI）成立於2007年，通過在社區環境中提供高度專業化、基於價值的癌症護理來推動腫瘤學發展。TOI爲超過180萬名患者提供尖端的循證癌症護理，包括臨床試驗、輸血和傳統上與最先進的醫療服務組織相關的其他護理提供模式。TOI 擁有 110 多名臨床醫生和 70 多個診所，而且還在不斷增長，正在使腫瘤學向更好的方向發展。欲了解更多信息，請訪問 www.theoncologyinstitute。
Contacts
聯繫人
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
投資者
索爾伯裏戰略傳播
investors@theoncologyinstitute.com
譯文內容由第三人軟體翻譯。